{ "case_number": "CAC-UDRP-107480", "time_of_filling": "2025-04-11 08:14:16", "domain_names": [ "zolgensmaintrathecal.com" ], "case_administrator": " Iveta Špiclová (Czech Arbitration Court) (Case admin)", "complainant": [ "Novartis AG" ], "complainant_representative": "Abion GmbH", "respondent": [ "Buy this domain on Dan.com ----" ], "respondent_representative": null, "factual_background": "

FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:<\/p>\n

    \n
  1. The Complainant is a global healthcare company based in Switzerland. Its products are manufactured and sold in many regions worldwide. <\/li>\n
  2. Since 2019 the Novartis Group manufactures the drug ZOLGENSMA, a prescription gene therapy used to treat children less than 2 years old with spinal muscular atrophy. ZOLGENSMA is safe and effective when delivered intrathecally, meaning directly into the fluid bathing the brain and spinal cord.<\/li>\n
  3. The Respondent registered the disputed domain name on 1 April 2025.<\/li>\n
  4. According to the undisputed evidence provided by the Complainant, the disputed domain name resolves to GoDaddy.com LLC’s domain broker service web page where it is being offered for sale at a buy-now price of USD 2.888.<\/li>\n<\/ol>", "other_legal_proceedings": "

    The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

    The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n

    No administratively compliant Response has been filed.<\/p>", "rights": "

    The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

    The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

    The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

    The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Tobias Malte Müller" ], "date_of_panel_decision": "2025-05-28 00:00:00", "informal_english_translation": "

    It results from the undisputed evidence before the Panel that the Complainant is the registered owner of several international trademarks ZOLGENSMA<\/strong> for goods in class 5, in particular:<\/p>\n